second
annual
meet
american
academi
nanomedicin
aanm
held
nation
acadmi
scienc
build
washinton
dc
septemb
program
includ
two
nobel
prize
laureat
lectur
two
keynot
lectur
invit
outstand
stateinart
lectur
present
special
concurr
symposia
addit
poster
present
meet
address
differ
area
nanomedicin
research
present
meet
outstand
investig
research
field
second
annual
meet
aanm
great
success
meet
provid
investig
differ
world
area
forum
opportun
discuss
believ
nanomedicin
research
develop
rapidli
futur
aanm
invit
basic
clinic
research
world
join
excit
research
second
annual
meet
american
academi
nanomedicin
aanm
held
nation
academi
scienc
build
washington
dc
septemb
open
ceremoni
held
morn
septemb
aanm
presid
chime
wei
md
phd
welcom
attende
extend
deep
appreci
thank
present
attende
contribut
meet
figur
mr
joe
mok
chair
governort
committe
maryland
gave
wonder
messag
welcom
everybodi
came
maryland
attend
import
meet
tachung
yih
phd
vice
presid
aanm
gave
thought
address
encourag
attende
continu
effort
advanc
nanomedicin
research
donald
tomelia
phd
vice
chair
aanm
organ
program
committe
summar
aanm
program
provid
attende
inform
present
aanm
symposia
jame
castracan
phd
member
board
director
aanm
summar
aanm
membership
fellowship
develop
futur
strategi
marianna
foldvari
phd
cochair
aanm
intern
committe
summar
aanm
intern
collabor
research
project
intern
research
activ
develop
presidenti
lectur
chime
wei
md
phd
john
hopkin
univers
summar
new
publish
unpublish
find
result
nanomedicin
research
area
also
review
new
nanotechnolog
clinic
applic
nanomedicin
develop
past
year
mani
import
research
result
publish
nanomedicin
research
area
signific
investig
lie
develop
platform
technolog
includ
nanoscal
molecular
imag
drug
deliveri
gene
deliveri
diagnost
approach
dendrimerbas
nanomedicin
develop
protein
mimicri
research
nanopharmaceut
diagnost
imag
contrast
agent
target
drug
deliveri
cancer
cell
biosensor
nanoscal
materi
provid
uniqu
power
technolog
detect
biolog
chemic
speci
aid
diseas
diagnosi
discoveri
screen
new
drug
molecul
develop
cancer
therapi
monitor
diagnost
nanotechnolog
includ
cancerrel
genotyp
detect
gene
express
immunochem
analysi
well
nearli
realtim
monitor
patient
blood
cancer
cell
nanotechnolog
develop
clinic
applic
cardiovascular
neurolog
pulmonari
skin
renal
diseas
first
nobel
prize
laureat
lectur
baquaporin
water
channel
atom
structur
clinic
medicineq
peter
agr
md
nobel
prize
laureat
chemistri
duke
univers
school
medicin
summar
aquaporin
aqp
water
channel
structur
applic
clinic
medicin
figur
aqp
water
channel
protein
permit
high
water
permeabl
certain
biolog
membran
peopl
lack
water
caus
defect
urin
concentr
reduc
fluid
exchang
capillari
interstitium
lung
mutat
gene
encod
express
len
fiber
cell
result
famili
cataract
mutat
gene
encod
express
renal
collect
duct
princip
cell
result
nephrogen
diabet
insipidu
mistarget
normal
express
apic
membran
saliveri
lacrim
gland
acini
occur
sjogrent
syndrom
aquaporin
also
implic
brain
edema
muscular
dystrophi
anhidrosi
renal
tubular
acidosi
convers
glycerol
glucos
starvat
cystic
fibrosi
sever
dr
agr
receiv
honor
fellowship
aanm
figur
b
second
nobel
prize
laureat
lectur
bnanotechnolog
biolog
businessq
ivar
giaever
phd
nobel
prize
laureat
physic
appli
biophys
inc
indic
nanotechnolog
hold
much
futur
promis
make
thing
cheaper
better
figur
particular
dr
giaever
discuss
gener
immunolog
detector
util
small
indium
particl
detect
antibodi
also
describ
wholecel
biosensor
use
electr
field
obtain
inform
morpholog
cell
tissu
cultur
final
dr
giaever
discuss
mean
bring
nanotechnolog
market
mani
import
exampl
experi
dr
giaever
receiv
honor
fellowship
aanm
figur
b
keynot
lectur
belectron
cryomicroscopi
biolog
nanomachinesq
wah
chiu
phd
baylor
medic
colleg
demonstr
applic
electron
cryomicroscopi
determin
multipl
molecular
compon
perform
specif
biolog
function
figur
imag
reconstruct
method
use
reconstruct
threedimension
structur
singl
nanomachin
imag
subnanomet
resolut
mine
salient
structur
featur
within
molecular
compon
larg
nanomachin
daunt
task
comput
visual
tool
develop
extract
featur
ahelic
bsheet
protein
subunit
high
degre
reliabl
structur
subnanomet
resolut
combin
sequencebas
structur
predict
method
deriv
pseudo
atom
model
molecular
compon
nanomachin
dr
chiu
receiv
presidenti
award
aanm
figur
b
concurr
symposia
second
aanm
annual
meet
symposium
focus
differ
nanomedicin
research
area
cover
topic
basic
nanomedicin
clinic
nanomedicin
follow
summari
symposium
journalt
page
limit
publish
summari
sever
symposia
issu
nanomedicin
nanotechnolog
biolog
medicin
publish
summari
symposia
remain
appear
next
issu
symposium
focus
nanoscal
analysi
protein
misfold
aggreg
phenomena
critic
associ
neurodegen
disord
alzheim
parkinson
huntington
diseas
mention
field
medicin
dramat
advanc
establish
fundament
understand
key
event
lead
misfold
selfaggreg
protein
involv
variou
proteinfold
patholog
four
speaker
symposium
dr
yuri
lyubchenko
outlin
approach
detect
analysi
protein
misfold
state
protein
misfold
complex
phenomenon
facilit
imped
prevent
interact
variou
intracellular
metabolit
interprotein
interact
intracellular
nanomachin
control
protein
fold
fundament
understand
molecular
process
lead
misfold
selfaggreg
protein
provid
critic
inform
help
identifi
appropri
therapeut
rout
control
process
protein
misfold
fist
link
long
chain
event
eventu
lead
neurodegener
therefor
avail
method
capabl
detect
patholog
protein
conform
facilit
develop
novel
tool
diagnost
treat
diseas
earli
stage
develop
singlemolecul
forc
spectroscopi
atom
forc
microscop
propos
measur
strength
interprotein
interact
aggreg
capabl
atom
forc
microscop
manipul
tip
nanomet
scale
use
develop
nanotweez
approach
capabl
singlemolecul
select
antibodi
certain
type
protein
aggreg
role
oxid
stress
protein
misfold
aggreg
asynuclein
topic
dr
jeanchristoph
rochet
investig
link
complex
impair
sequencespecif
posttransl
modif
asynuclein
protein
isol
rotenonetr
cell
analyz
tandem
mass
spectrometri
found
rotenon
induc
variou
modif
ctermin
region
asynuclein
includ
oxid
methionin
nitrat
amin
tyrosin
phosphoryl
tyrosin
serin
modif
correl
increas
level
membranebound
oligomer
asynuclein
detect
fluoresc
lifetim
imag
microscopi
lipid
flotat
parallel
found
asynuclein
aggreg
toxic
suppress
antioxid
protein
dysfunct
case
famili
parkinson
diseas
current
goal
nanomedicin
determin
conform
behavior
asynuclein
influenc
sequencespecif
modif
use
singlemolecul
approach
present
dr
bori
akhremitchev
focus
analysi
thermodynam
asynuclein
fragment
critic
involv
protein
misfold
aggreg
interact
individu
molecul
studi
use
scan
forc
microscopybas
techniqu
report
energi
landscap
paramet
interact
includ
barrier
width
dissoci
rate
obtain
illustr
possibl
direct
measur
molecularlevel
paramet
investig
molecular
origin
misfoldingbas
protein
aggreg
effect
chemic
agent
prevent
hinder
aggreg
dr
robert
tycko
review
advanc
highresolut
studi
fibril
aggreg
achiev
use
solidst
nuclear
magnet
reson
techniqu
capabl
provid
sitespecif
constraint
secondari
tertiari
quaternari
structur
amyloid
fibril
demonstr
recent
work
fibril
form
fulllength
bamyloid
peptid
associ
alzheim
diseas
fragment
thereof
recent
result
focus
follow
area
develop
structur
model
bamyloid
fibril
grown
either
agit
quiescent
condit
develop
structur
model
fibril
form
amylin
peptid
associ
type
diabet
constraint
molecular
structur
fibril
form
yeast
prion
protein
dr
justin
hane
john
hopkin
univers
start
first
session
describ
new
biomateri
platform
target
intracellular
drug
deliveri
poli
etheranhydrid
polym
incorpor
poli
ethylen
glycol
peg
backbon
structur
polymer
one
sever
monom
sebac
acid
sa
also
known
safe
human
addit
peg
polym
backbon
allow
classic
poli
anhydrid
formul
nanoparticl
readili
resuspend
liquid
inject
inhal
dri
powder
microparticl
easili
aerosol
inhal
peg
coat
surfac
particl
natur
particl
prepar
allow
linkag
target
agent
free
end
peg
ie
end
attach
rest
polym
highli
select
target
poli
pegsa
particl
inflam
blood
vessel
demonstr
follow
attach
antibodi
molecul
upregul
lumin
side
inflam
endotheli
cell
collabor
prof
doug
goetz
ohio
univers
poli
pegsa
nanoparticl
transferrin
attach
free
end
peg
also
abl
penetr
target
cancer
cell
rapidli
transit
within
cell
perinuclear
region
particl
toxic
cancer
cell
relev
dose
free
drug
dr
richard
price
univers
virginia
next
discuss
use
ultrasoundassist
local
permeat
blood
vessel
microbubbl
destruct
method
enhanc
target
drug
includ
contain
within
nanoand
microparticl
microbubbl
hollow
microspher
shell
compos
albumin
current
use
clinic
contrast
agent
diagnost
ultrasound
dr
price
show
ultrasound
use
low
frequenc
caus
bubbl
target
region
explod
cavit
caus
signific
increas
local
permeabl
endothelium
drug
even
larg
particl
highli
target
deliveri
polym
nanoparticl
muscl
tissu
clearli
demonstr
anim
model
control
particl
penetr
depth
achiev
simpli
appli
ultrasound
without
microbubbl
case
particl
penetr
endothelium
interstitium
wherea
applic
ultrasound
microbubbl
led
particl
deliveri
endothelium
interstitium
result
suggest
techniqu
may
provid
altern
molecular
target
varieti
diseas
dr
lawrenc
tamarkin
cytimmun
scienc
inc
next
spoke
companyt
colloid
goldbas
system
target
drug
deliveri
tumor
aurimun
tumor
necrosi
factor
tnfa
bound
surfac
colloid
gold
nanoparticl
averag
diamet
nm
nanoparticl
pegyl
reduc
clearanc
reticuloendotheli
system
evid
liver
spleen
uptak
nanoparticl
minim
compar
uptak
tumor
mice
provid
aurimun
administ
two
dog
natur
occur
tumor
rabbit
case
administr
caus
fever
caus
hypotens
hypotens
histor
dose
limit
treatment
cancer
tnfa
base
promis
preclin
result
aurimun
product
scale
certifi
gmp
current
studi
nation
cancer
institutesponsor
phase
trial
patient
advancedstag
cancer
dr
esther
chang
georgetown
univers
next
provid
provoc
result
target
cation
liposom
treatment
improv
imag
variou
tumor
type
note
tumor
need
iron
grow
therefor
typic
express
high
level
transferrin
receptor
surfac
dr
changt
group
use
antitransferrin
receptor
singlechain
antibodi
fragment
target
ligand
liposom
deliveri
platform
dr
chang
gave
overview
laboratoryt
extens
experi
liposom
drug
carrier
varieti
tumor
type
includ
head
neck
breast
prostat
kidney
pancreat
demonstr
antitumor
effect
sever
drug
drug
type
includ
dna
small
interf
rna
small
molecul
dr
chang
report
technolog
enter
clinic
trial
unit
state
final
dr
chang
also
show
contrast
agent
magnet
reson
imag
could
encapsul
liposom
lead
improv
sensit
resolut
detect
metastat
lesion
dr
hamid
ghandehari
univers
maryland
baltimor
cap
first
drug
deliveri
session
overview
way
nanoscal
medicin
might
improv
control
particl
structur
use
special
chemistri
fabric
method
note
carrier
use
control
tempor
spatial
deliveri
bioactiv
agent
typic
made
polym
liposom
inorgan
particl
polydispers
size
distribut
make
predict
biodistribut
subcellular
fate
challeng
also
point
polym
studi
drug
deliveri
made
random
copolymer
techniqu
limit
control
monom
sequenc
polym
molecular
weight
molecular
weight
distribut
may
affect
perform
given
nanomedicin
platform
technolog
dr
ghandehari
describ
sever
mean
polym
nanosystem
could
made
better
definit
structur
dimens
includ
laboratoryt
experi
n
methacrylamid
copolym
poli
amido
amin
dendrim
recombin
polymer
gene
carrier
silica
nanotub
discuss
relationship
carrier
structur
nanoscal
function
target
drug
deliveri
second
session
drug
deliveri
nanomedicin
symposium
began
talk
dr
kathleen
j
stebe
john
hopkin
univers
import
control
interfaci
phenomena
product
nanoparticl
enhanc
particl
stabil
function
dr
stebe
discuss
interfaci
properti
nanoparticl
could
control
fabric
influenc
properti
perform
nanomedicin
product
final
surfac
properti
nanoparticl
dictat
everyth
whether
aggreg
vivo
effect
circul
find
target
understand
complex
kinet
thermodynam
nanoparticl
system
synthesi
formul
critic
yet
underappreci
scienc
improv
perform
nanomedicin
platform
dr
jimmi
yun
singapor
nanomateri
technolog
next
discuss
companyt
effort
develop
effect
process
largescal
product
pharmaceut
nanoparticl
excel
control
size
size
distribut
morpholog
highgrav
precipit
method
formul
method
may
valuabl
enhanc
perform
drug
use
aerosol
solid
dosag
form
dr
tsuneya
ikezu
univers
nebraska
medic
center
discuss
groupt
find
amyloidb
aggreg
stubulin
induc
phosphoryl
reduc
microtubul
extens
studi
import
implic
understand
potenti
molecular
mechan
underli
impair
neuron
plastic
brain
alzheim
patient
may
provid
potenti
therapeut
target
treat
alzheim
diseas
dr
haiquan
mao
john
hopkin
univers
cap
second
drug
deliveri
session
discuss
new
polyphosphoest
block
copolym
system
selfassembl
micel
averag
diamet
nm
improv
gene
express
liver
use
new
polym
nanoparticl
platform
technolog
demonstr
polyphosphoest
micel
potenti
treat
liverassoci
diseas
gene
medicin
approach
cell
basic
unit
anim
matter
cell
consist
astonish
collect
differ
individu
inanim
nanostructur
order
aggreg
nanostructur
tabl
three
five
talk
symposium
basic
biolog
bent
other
technolog
charact
one
technolog
talk
startup
compani
spun
univers
other
academia
dr
anja
nohe
chemic
biolog
engin
univers
main
spoke
mous
genet
model
bone
stem
cell
nanoscal
receptor
dynam
method
imag
microscopyin
particular
fourier
imag
correl
spectroscopi
fluoresc
reson
energi
transferallow
assess
receptor
protein
dynam
within
microdomain
plasma
membran
dr
ari
requicha
laboratori
molecular
robot
univers
southern
california
describ
binstrumentedq
cellular
system
could
develop
sensoractu
network
distribut
robot
open
new
direct
biomed
research
eventu
realiz
multipl
nanosensor
provid
continu
stream
realtim
multimod
complementari
data
behavior
group
cell
singl
cell
increas
human
understand
life
process
tissu
cellular
molecular
level
dr
han
bae
pharmaceut
pharmaceut
chemistri
univers
utah
spoke
use
phsensit
polymer
mix
micel
construct
block
copolym
poli
lhistidin
bpeg
poli
llactid
bpeg
target
tumor
overcom
multipledrug
resist
approach
could
result
paradigm
shift
treatment
solid
tumor
monoclon
antibodyreceptorbas
target
ph
shiftbas
target
dr
hayni
bionanosystem
engin
laboratori
artifici
cell
technolog
inc
explain
polypeptid
multilay
nanofilm
platform
technolog
adapt
develop
differ
biomed
applic
artifici
extracellular
matrix
tissu
regener
artifici
red
blood
cell
oxygen
therapeut
artifici
virus
synthet
vaccin
develop
case
peptid
design
nanofilm
architectur
tailor
specif
purpos
mimick
key
properti
cell
virus
biomacromolecul
microscal
nanoscal
dr
deni
wirtz
chemic
biomolecular
engin
john
hopkin
univers
show
probe
cytoskelet
dynam
ovarian
cancer
progress
multipl
particl
track
bnanorheologyq
cell
correspond
two
known
pathway
ovarian
cancer
progress
vari
distinctli
cytoplasm
viscos
progress
medicin
requir
deeper
understand
cell
tissu
system
behavior
depend
properti
subcellular
nanostructur
nanostructur
compon
molecular
assembl
pharmacolog
nanomedicin
symposium
four
talk
present
latest
advanc
drug
discoveri
deliveri
first
talk
dr
jeann
hardi
univers
massachusettsamherst
present
sitedirect
approach
call
btetheringq
alloster
site
key
protein
exploit
drug
discoveri
site
surfac
protein
redesign
control
small
molecul
choic
recent
advanc
caspas
famili
cystein
proteas
present
reveal
pathway
inhibit
caspas
regul
apoptosi
dr
wafik
eldeiri
univers
pennsylvania
school
medicin
present
novel
optic
imag
approach
monitor
molecular
event
relev
tumor
progress
therapeut
respons
approach
introduc
genet
alter
human
cell
along
bioluminesc
report
gene
determin
role
specif
oncogen
tumor
suppressor
gene
control
tumor
progress
therapeut
respons
molecular
beacon
use
highthroughput
screen
small
molecul
modul
signal
lead
tumor
cell
death
approach
includ
evalu
bioluminesc
tumor
anim
drugtarget
valid
therapeut
efficaci
overal
goal
present
dr
eldeiri
develop
new
approach
drug
screen
target
valid
acceler
preclin
phase
anticanc
drug
develop
bring
new
agent
clinic
trial
dr
scott
l
diamond
univers
pennsylvania
director
penn
center
molecular
discoveri
report
breakthrough
microarray
design
screen
nanoliterscal
biochem
reaction
analyz
matrixassist
laser
desorptionionizationtimeofflight
mass
spectrometri
sensit
dr
diamond
describ
multiplex
screen
across
numer
proteas
identifi
nanomolar
inhibitor
human
cathepsin
l
potent
inhibitor
sever
acut
respiratori
syndrom
coronaviru
entri
dr
david
needham
duke
univers
describ
temperaturesensit
liposom
approach
drug
deliveri
group
introduc
phase
aanm
rapidli
expand
intern
organ
membership
world
symposium
xvi
excit
represent
intern
scope
nanomedicin
bionanotechnolog
research
addit
unit
state
eight
countriest
lead
research
gave
overview
current
state
research
nanomedicin
respect
countri
follow
countri
repres
canada
nanomedicin
present
explos
number
opportun
improv
peoplet
live
great
divers
research
area
develop
worldwid
unit
state
leader
canada
import
nanomedicin
research
area
includ
intellig
drug
deliveri
system
vaccin
gene
deliveri
nanosystem
polymer
system
devic
biochip
labonachip
artifici
cell
anticanc
immun
neuraland
musculoskelet
system
nanoscal
target
tissu
cellular
engin
novel
biomateri
molecular
imag
hong
kong
dna
electron
microfluid
devic
metal
nanoparticl
nanofib
biopolymer
materi
investig
diagnost
tissu
engin
applic
india
nanomedicin
research
includ
drug
deliveri
dendrimerbas
nanoarchitectur
control
target
deliveri
anticanc
bioactiv
mitochondri
drug
target
gene
therapi
genet
disord
like
diabet
cancer
use
dendrimerbas
nano
carrier
develop
dna
vaccin
leichmania
donovani
stem
cell
research
korea
activ
design
intellig
microsystem
biomed
devic
wherea
japan
imag
drug
deliveri
applic
nanosci
medic
treatment
alreadi
strong
second
intern
confer
americajapan
nanomedicin
societi
held
japan
april
nanotechnolog
program
russia
recent
launch
includ
nanomedicin
research
across
countri
singapor
biomed
scienc
lead
area
nanotechnolog
support
strong
economi
panel
discuss
present
conclud
futur
vision
true
intern
effort
develop
nanomedicinerel
technolog
discoveri
regular
updat
present
annual
aanm
meet
symposium
dealt
highlight
relat
toxicolog
skin
eye
respiratori
cardiovascular
effect
well
interpret
polym
toxicolog
dr
nanci
monteirorivier
discuss
effect
multiwal
carbon
nanotub
fulleren
derivat
fulleren
quantumdot
effect
human
epiderm
keratinocyt
penetr
skin
nanomateri
depict
inflammatori
effect
alter
gene
express
protein
ultrastructur
local
within
skin
cell
irrit
profil
quantum
dot
differ
size
surfac
chemistri
depict
uniqu
profil
penetr
skin
dr
gerard
lutti
talk
use
differ
type
inject
nanoparticl
deliv
gene
rabbit
eye
chitosan
pcep
magnet
nanoparticl
show
toxic
vitro
demonstr
toxic
vivo
nanoparticl
capabl
transfect
cell
chitosan
caus
inflamm
eye
magnet
nanoparticl
least
toxic
transfect
specif
cell
type
eye
dr
randal
schneider
discuss
consider
must
taken
account
use
polym
nanoparticl
biomed
applic
emphas
complex
nanoparticl
predict
model
current
use
may
suitabl
nanoparticl
therefor
import
studi
behavior
differ
type
nanoparticl
biolog
environ
fulli
character
materi
full
interpret
made
dr
petia
simeonova
discuss
research
singlewal
carbon
nanotub
instil
lung
mice
demonstr
dosedepend
increas
oxid
vascular
damag
studi
also
demonstr
singlewal
carbon
nanotub
modifi
lipid
profil
gener
acceler
plaqu
format
mous
model
arteriosclerosi
find
demonstr
lung
toxic
also
depict
cardiovascular
effect
studi
present
toxicolog
nanomedicin
symposium
show
nanomateri
may
toxic
specif
condit
extens
studi
interact
materi
bodi
essenti
full
interpret
made
nanotechnolog
product
develop
cycl
incorpor
evalu
potenti
risk
reduct
earliest
stage
hidezo
mori
md
phd
summar
groupt
nation
project
japan
name
nanolevel
imag
molecular
structur
function
project
mori
group
analyz
structur
fundament
protein
human
diseas
select
complex
cardiac
troponin
calcium
sensit
vascular
apoptosisinduc
protein
calcineurin
homolog
protein
target
figur
protein
express
escherichia
coli
isol
crude
snake
venom
purifi
final
crystal
hangingdrop
method
xray
diffract
data
collect
structur
determin
subnanolevel
structur
imag
use
structurebas
drug
design
treat
cardiovascular
diseas
cancer
shume
nie
phd
talk
semiconductor
quantum
dot
link
biotarget
biorecognit
ligand
monoclon
antibodi
peptid
small
molecul
nanoparticl
use
target
tumor
antigen
biomark
well
tumor
vasculatur
high
affin
specif
bmesoscopicq
size
rang
nm
diamet
quantum
dot
polymer
nanoparticl
also
surfac
area
function
group
link
multipl
diagnost
eg
optic
radiosotop
magnet
therapeut
eg
anticanc
agent
kenneth
wong
phd
report
topic
deliveri
silver
nanoparticl
reduc
system
inflamm
burn
promot
wound
heal
team
investig
wound
heal
properti
silver
nanoparticl
anim
model
found
rapid
heal
better
cosmet
appear
dosedepend
manner
furthermor
quantit
polymeras
chain
reaction
immunohistochemistri
proteom
studi
team
show
silver
nanoparticl
exert
posit
effect
antimicrobi
properti
reduct
wound
inflamm
modul
fibrogenet
cytokin
result
given
insight
action
silver
provid
novel
therapeut
direct
wound
treatment
clinic
practic
yoshinobu
bana
phd
describ
nanofabr
molecular
nanotechnolog
nanomateri
bioanalysi
biomed
applic
array
nanopillar
nm
wide
nm
tall
success
applic
fast
separ
dna
within
second
nanobal
diamet
nm
develop
success
appli
fast
separ
dna
fragment
base
pair
kilobas
pair
bacteria
cellulos
biofib
diamet
nm
found
use
highli
sensit
detect
biomolecul
base
optic
confin
effect
nanobiodevic
use
fast
separ
protein
sampl
sever
kilodalton
kda
within
second
joe
kao
phd
report
possibl
control
biolog
light
bphototriggerq
bcage
moleculeq
biolog
inact
photosensit
precursor
rapidli
transform
fulli
bioactiv
molecul
upon
exposur
flash
light
bioactiv
molecul
thu
gener
act
biochem
trigger
hormon
neurotransmitt
second
messeng
enzym
modul
therefor
combin
focus
light
puls
cage
molecul
repres
simpl
methodolog
manipul
biolog
live
cell
tissu
excel
tempor
spatial
resolut
specif
applic
technolog
manipul
neurotransmiss
singl
synaps
stimul
singl
nerv
termin
discuss
year
nine
finalist
young
investig
award
yia
nine
finalist
gave
platform
present
topic
repres
novel
excit
area
nanomedicin
award
present
two
categori
scientist
senior
junior
scientist
graduat
student
postdoctor
fellow
new
investig
junior
yia
scientist
jeanchristoph
rochet
purdu
univers
receiv
first
place
work
develop
nanoimagingbas
approach
detect
analysi
protein
misfold
state
gengfeng
zheng
harvard
univers
receiv
second
place
develop
nanowir
transistor
array
largescal
labelfre
realtim
parallel
electr
detect
varieti
biomolecul
rang
small
molecul
protein
virus
third
place
award
winston
timp
massachusett
institut
technolog
develop
livingcel
microarray
array
optic
trap
abl
manipul
hundr
bacteria
ten
mammalian
cell
array
livingcel
microarray
observ
time
assay
gene
express
cell
viabil
senior
yia
group
first
place
award
went
justin
hane
john
hopkin
univers
group
develop
new
famili
polym
poli
etheranhydrid
nanoparticl
design
select
adhes
desir
cell
type
nonadhes
obstacl
bodi
might
prevent
target
deliveri
second
place
went
xiaohua
huang
univers
californiasan
diego
effort
develop
technolog
capabl
rapidli
sequenc
human
genom
littl
third
place
recipi
susan
l
beami
remp
sandia
nation
laboratori
contribut
understand
ion
transport
aqueou
biolog
environ
purpos
design
new
transport
devic
relev
medic
environment
applic
poster
session
second
annual
meet
aanm
present
poster
cover
basic
biosensor
cellular
dendrimerbas
diagnost
engin
experiment
genet
neurolog
oncolog
polici
toxicolog
nanomedicin
present
poster
excel
discuss
posit
step
build
futur
pathway
variou
research
area
first
place
best
poster
award
went
rutledg
g
ellisbehnk
massachusett
institut
technolog
second
place
best
poster
award
went
lajo
p
balogh
nanobiotechnolog
center
roswel
park
cancer
institut
third
place
best
poster
award
went
winston
timp
massachusett
institut
technolog
welcom
recept
research
investig
opportun
discuss
dayt
lectur
present
figur
wenchi
wei
chime
weit
daughter
perform
chines
music
instrument
guzheng
recept
figur
year
aanm
volunt
staff
team
work
hard
provid
wonder
servic
confer
greatli
appreci
aanm
staff
teamt
excel
work
dr
ling
xu
senior
coordin
aanm
staff
team
receiv
aanm
servic
award
recept
figur
aanm
guid
academ
activ
provid
leadership
lead
research
field
aanm
fellowship
committe
approv
elect
new
fellow
join
academi
would
like
invit
qualifi
scientist
investig
appli
aanm
fellowship
join
us
develop
nanomedicin
research
conclus
second
annual
meet
aanm
great
success
figur
meet
provid
investig
differ
world
area
forum
opportun
discuss
believ
nanomedicin
research
develop
rapidli
futur
aanm
invit
basic
clinic
research
world
join
excit
research
sincer
appreci
everyon
contribut
confer
look
forward
see
everyon
next
year
third
annual
meet
aanm
septemb
san
diego
california
